ArticlePharmaceuticals (Basel, Switzerland)2024

HGFK1 Enhances the Anti-Tumor Effects of Angiogenesis Inhibitors via Inhibition of CD90+ CSCs in Hepatocellular Carcinoma.

Tao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.